By Business/Source
Currency:USD
2025/FY
Stock NameRevenueRatio
Clinical Trials50.58M99.55%
Healthcare2.51M4.94%
Royalty Income-2.28M-4.48%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
Australia50.81M100.00%